Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04265222 · ClinicalTrials.gov registry record · NA
Cam Decompression Utilizing the Stryker Hip-Check Software Platform
A NA study of Femoroacetabular Impingement, sponsored by American Hip Institute.
- Active
- Registry status
- NA
- Development phase
- 43
- Enrollment target
- 1
- Study location
NCT04265222: Active NA study of Femoroacetabular Impingement, sponsored by American Hip Institute.
NCT04265222 is a NA study of Femoroacetabular Impingement that is active but no longer recruiting, run by American Hip Institute. The registered enrollment target is 43 participants, below the 1,364-participant average among 8 other Femoroacetabular Impingement trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04265222, a NA study of Femoroacetabular Impingement, is active but no longer recruiting, sponsored by American Hip Institute.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 43 participants
- Enrollment target
- 1
- Study location
Study Summary
Accurate femoroplasty has been shown to be critical in achieving success following treatment of femoroacetabular impingement (Matsuda, Schnieder, and Sehgal 2014; Mansor et al. 2018; Larson et al. 2014). Nearly 75% of cases undergoing revision hip arthroscopy do so due to residual femoroacetabular impingement (Ricciardi et al. 2014). Femoroplasty remains one of the most challenging and time-consuming procedures in hip arthroscopy and methods to improve accuracy and optimize time management are essential. The HipCheck system is a navigational tool based on intraoperative fluoroscopy that aims at improving accuracy and efficiency of femoroplasty. The objective of this study is to two-fold. (1) To prospectively compare surgical and (2) radiographic outcomes of patients undergoing femoroplasty with guidance of Stryker's HipCheck system to patients undergoing femoroplasty with conventional fluoroscopic methods.
Conditions Studied
Interventions
- DEVICE Hipcheck Software
- OTHER Conventional Fluoroscopy
Study Locations (1)
Illinois
- American Hip Institute - Des Plaines
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 43 participants |
| Start Date | 2020-03-01 |
| Est. Completion | 2024-12 |
| Phase | NA |
What the registry record for NCT04265222 still lists
NCT04265222 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 43 participants, a relatively small participant target, below the 1,364-participant average among 8 other Femoroacetabular Impingement trials with a reported enrollment target (97% lower).
The record links to 1 condition, with Femoroacetabular Impingement appearing as the primary indexed condition, and to 2 interventions - of which Hipcheck Software is the first listed.
NCT04265222 reports a single indexed study location in Illinois.
Frequently Asked Questions
What is clinical trial NCT04265222 about?
NCT04265222 is a clinical study titled "Cam Decompression Utilizing the Stryker Hip-Check Software Platform". Accurate femoroplasty has been shown to be critical in achieving success following treatment of femoroacetabular impingement (Matsuda, Schnieder, and Sehgal 2014; Mansor et al. 2018; Larson et al. 2014). Nearly 75% of cases undergoing revision hip arthroscopy do so due to residual femoroacetabular i...
What is the current status of trial NCT04265222?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 43 participants. The study started on 2020-03-01. Estimated completion is 2024-12.
What conditions does trial NCT04265222 study?
This clinical trial studies the following conditions: Femoroacetabular Impingement.
What interventions are being tested in trial NCT04265222?
The interventions under investigation include: Hipcheck Software (DEVICE), Conventional Fluoroscopy (OTHER).
Who is sponsoring clinical trial NCT04265222?
This trial is sponsored by American Hip Institute, which has 4 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04265222 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Femoroacetabular Impingement
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04265222's enrollment target sits among peer trials
43 8th of 8 higher than 1 of 8 other Femoroacetabular Impingement trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Femoroacetabular Impingement trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Early Feasibility Study of Cartilage Defect Repair
RECRUITING · NA
-
Arthroscopic Labral Repair Versus Physical Therapy for Tears of the Acetabular Labrum
ACTIVE NOT RECRUITING · NA
-
An Evaluation of Hip Preservation Outcomes
RECRUITING
-
Effect of PRP, PPP, & BMAC on Functional Outcomes Following Hip Arthroscopy for Acetabular Labral Pathologies
RECRUITING · Phase 3
-
Knotless Implants As an Alternative for Capsular Closure in Primary Hip Arthroscopy: a Prospective, Multi-Center Study
RECRUITING · Phase 4
-
Use of BMAC With Hip Arthroscopy Treatment of FAI and Labral Tear
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03726359 · 43 participants · Phase 1
Phase I Study of Fractionated Stereotactic Radiation Therapy
- NCT03850418 · 43 participants · Phase 2
Azacitidine and Chimerism in MDS or AML Patients After Allogeneic Stem Cell Transplant
- NCT04144023 · 43 participants · Phase 1
A Vaccine (H2NVAC) Before Surgery for the Treatment of HER2-Expressing Ductal Carcinoma In Situ
- NCT04176718 · 43 participants · Phase 2
Daratumumab, Carfilzomib, Pomalidomide, Dexamethasone In MM
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI